Skip to main content
. 2016 Sep 26;21(1):85–93. doi: 10.1007/s40291-016-0237-9

Fig. 5.

Fig. 5

a Immune cell plasma membrane scoring of NSCLC samples. b Immune cell plasma membrane scoring of melanoma samples. NSCLC non–small-cell lung cancer, PD-L1 programmed death-ligand